These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 33670475)

  • 1. The COVID-19 Pandemic: Disproportionate Thrombotic Tendency and Management Recommendations.
    Karim S; Islam A; Rafiq S; Laher I
    Trop Med Infect Dis; 2021 Feb; 6(1):. PubMed ID: 33670475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Coagulopathies, thrombotic risk and anticoagulation in COVID-19].
    Peters P; Sprynger M; Lancellotti P; Oury C
    Rev Med Liege; 2020 Sup; 75(S1):86-93. PubMed ID: 33211428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation.
    Miesbach W; Makris M
    Clin Appl Thromb Hemost; 2020; 26():1076029620938149. PubMed ID: 32677459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [COVID-19 and thromboprophylaxis: Recommendations for our clinical practice in Primary Care].
    Piera Carbonell A; Frías Vargas M; García Vallejo O; García Lerín A; Cabrera Ferriols MA; Peiró Morant J; Carrasco Carrasco E;
    Semergen; 2020 Oct; 46(7):479-486. PubMed ID: 33046353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Emerging Threat of (Micro)Thrombosis in COVID-19 and Its Therapeutic Implications.
    McFadyen JD; Stevens H; Peter K
    Circ Res; 2020 Jul; 127(4):571-587. PubMed ID: 32586214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thromboembolic events and Covid-19.
    Ribes A; Vardon-Bounes F; Mémier V; Poette M; Au-Duong J; Garcia C; Minville V; Sié P; Bura-Rivière A; Voisin S; Payrastre B
    Adv Biol Regul; 2020 Aug; 77():100735. PubMed ID: 32773098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [COVID-19: Coagulopathy and thrombosis].
    Tazi Mezalek Z
    Rev Med Interne; 2021 Feb; 42(2):93-100. PubMed ID: 33509669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study.
    Helms J; Tacquard C; Severac F; Leonard-Lorant I; Ohana M; Delabranche X; Merdji H; Clere-Jehl R; Schenck M; Fagot Gandet F; Fafi-Kremer S; Castelain V; Schneider F; Grunebaum L; Anglés-Cano E; Sattler L; Mertes PM; Meziani F;
    Intensive Care Med; 2020 Jun; 46(6):1089-1098. PubMed ID: 32367170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra).
    Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G; Toniato E
    J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1623-1627. PubMed ID: 32744052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 Associated Coagulopathy and Thrombotic Complications.
    Mezalek ZT; Khibri H; Ammouri W; Bouaouad M; Haidour S; Harmouche H; Maamar M; Adnaoui M
    Clin Appl Thromb Hemost; 2020; 26():1076029620948137. PubMed ID: 32795186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unique transcriptional changes in coagulation cascade genes in SARS-CoV-2-infected lung epithelial cells: A potential factor in COVID-19 coagulopathies.
    FitzGerald ES; Jamieson AM
    bioRxiv; 2020 Jul; ():. PubMed ID: 32676594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium.
    Gorog DA; Storey RF; Gurbel PA; Tantry US; Berger JS; Chan MY; Duerschmied D; Smyth SS; Parker WAE; Ajjan RA; Vilahur G; Badimon L; Berg JMT; Cate HT; Peyvandi F; Wang TT; Becker RC
    Nat Rev Cardiol; 2022 Jul; 19(7):475-495. PubMed ID: 35027697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. D-Dimer, Fibrinogen, and IL-6 in COVID-19 Patients with Suspected Venous Thromboembolism: A Narrative Review.
    Eljilany I; Elzouki AN
    Vasc Health Risk Manag; 2020; 16():455-462. PubMed ID: 33223833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study.
    Liao D; Zhou F; Luo L; Xu M; Wang H; Xia J; Gao Y; Cai L; Wang Z; Yin P; Wang Y; Tang L; Deng J; Mei H; Hu Y
    Lancet Haematol; 2020 Sep; 7(9):e671-e678. PubMed ID: 32659214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trial.
    Houston BL; Lawler PR; Goligher EC; Farkouh ME; Bradbury C; Carrier M; Dzavik V; Fergusson DA; Fowler RA; Galanaud JP; Gross PL; McDonald EG; Husain M; Kahn SR; Kumar A; Marshall J; Murthy S; Slutsky AS; Turgeon AF; Berry SM; Rosenson RS; Escobedo J; Nicolau JC; Bond L; Kirwan BA; de Brouwer S; Zarychanski R
    Clin Trials; 2020 Oct; 17(5):491-500. PubMed ID: 32815416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coagulopathy, thromboembolic complications, and the use of heparin in COVID-19 pneumonia.
    Costanzo L; Palumbo FP; Ardita G; Antignani PL; Arosio E; Failla G;
    J Vasc Surg Venous Lymphat Disord; 2020 Sep; 8(5):711-716. PubMed ID: 32561465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coagulopathies in novel coronavirus (SARS-CoV-2) pandemic: Emerging evidence for hematologists.
    Al-Subaie AM
    Saudi J Biol Sci; 2021 Jan; 28(1):956-961. PubMed ID: 33169062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coagulopathy in COVID-19 and Its Implication for Safe and Efficacious Thromboprophylaxis.
    Langer F; Kluge S; Klamroth R; Oldenburg J
    Hamostaseologie; 2020 Aug; 40(3):264-269. PubMed ID: 32498097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of bleeding risk of interventional techniques: a best evidence synthesis of practice patterns and perioperative management of anticoagulant and antithrombotic therapy.
    Manchikanti L; Falco FJ; Benyamin RM; Caraway DL; Kaye AD; Helm S; Wargo BW; Hansen H; Parr AT; Singh V; Swicegood JR; Smith HS; Schultz DM; Malla Y; Hirsch JA
    Pain Physician; 2013 Apr; 16(2 Suppl):SE261-318. PubMed ID: 23615893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.